The success rate over the past three years boasts over 90% and has been adopted by many pharmaceutical companies.
For features 1 to 3, please refer to the seven characteristics of our monoclonal antibody production contract service.
4. Customization through molecular engineering
It is possible to add various tags to antibodies or produce various fusion proteins. Additionally, dimerization can be achieved using a helix-turn-helix motif, which can enhance antigen cross-linking ability and improve affinity.
5. Abundant options
As an option, we can also handle the preparation of antigens. Conversions to human IgG, IgA, or mouse chimeric IgG, as well as affinity enhancement after antibody production, increasing the number of candidate antibodies, and additional antibody preparations are possible.
6. No cost if ELISA-positive antibodies are not obtained
Our service boasts a success rate of over 90%. Based on this confidence backed by our success rate, there will be no charge if ELISA-positive antibody clones are not obtained against the antigen.
7. Continuous supply of antibodies
Antibodies are backed up in three formats: whole cells, plasmid DNA, and DNA sequence information, ensuring that all antibodies can be rapidly reproduced from these backups, guaranteeing a continuous supply.
*Please feel free to contact us for more details.
